Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.26 is 67% above its 5-year average of -3.86, near the high end of its 5-year range (-10.02–-0.47).
57.50% below its 12-month average of -0.80.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -0.91.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.26
EARNINGS PER SHARE (EPS) AVG TTM
-0.80
EARNINGS PER SHARE (EPS) AVG 3Y
-2.79
EARNINGS PER SHARE (EPS) AVG 5Y
-3.86
EARNINGS PER SHARE (EPS) AVG 10Y
-13.77
EARNINGS PER SHARE (EPS) AVG 15Y
-22.06
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-57.50%
CURRENT VS 3Y AVG
+54.80%
CURRENT VS 5Y AVG
+67.40%
CURRENT VS 10Y AVG
+90.85%
CURRENT VS 15Y AVG
+94.29%
CURRENT VS 20Y AVG
N/A
Grace Therapeutics, Inc.
Market Cap
$34.44M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
Market Cap
$33.32M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.68
3Y Avg
-0.92
5Y Avg
-0.73
Market Cap
$35.82M
Earnings Per Share (EPS)
0.94
TTM Avg
-0.29
3Y Avg
-1.25
5Y Avg
-1.59
Market Cap
$36.32M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
Market Cap
$32.55M
Earnings Per Share (EPS)
-7.30
TTM Avg
-11.70
3Y Avg
-7.29
5Y Avg
-5.93
Market Cap
$36.45M
Earnings Per Share (EPS)
-13.84
TTM Avg
-117.78
3Y Avg
-126.66
5Y Avg
-275.31
Market Cap
$32.34M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$32.31M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$36.64M
Earnings Per Share (EPS)
-0.40
TTM Avg
-0.21
3Y Avg
-0.17
5Y Avg
-0.13
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $34.44M | -1.26 | -0.80 | -2.79 | -3.86 |
| HeartBeam, Inc. (BEAT)vs › | $33.32M | -0.52 | -0.68 | -0.92 | -0.73 |
| Elutia Inc (ELUT)vs › | $35.82M | 0.94 | -0.29 | -1.25 | -1.59 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | -2.13 | -3.42 | -5.72 | -5.72 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.55M | -7.30 | -11.70 | -7.29 | -5.93 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.45M | -13.84 | -117.78 | -126.66 | -275.31 |
| Context Therapeutics Inc. (CNTX)vs › | $32.34M | -0.48 | -0.42 | -0.82 | -1.14 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -2.56 | -5.45 | -15.27 | -9.79 |
| Accuray Incorporated (ARAY)vs › | $36.64M | -0.40 | -0.21 | -0.17 | -0.13 |
| DocGo Inc. (DCGO)vs › | $36.70M | -1.96 | -0.82 | -0.31 | -0.18 |
Trailing EPS (TTM)
$-1.26
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -0.47 |
| 2025-03-31 | -1.13 |
| 2024-03-31 | -1.83 |
| 2023-03-31 | -7.72 |
| 2022-03-31 | -2.02 |
| 2021-03-31 | -10.02 |
| 2020-03-31 | -20.45 |
| 2018-03-31 | -45.97 |
| 2017-03-31 | -34.30 |
| 2016-02-29 | -21.76 |
| 2015-02-28 | -8.52 |
| 2014-02-28 | -64.38 |
| 2013-02-28 | -42.04 |
| 2012-02-29 | -48.25 |
| 2011-02-28 | -29.16 |
| 2010-02-28 | -31.99 |
| 2009-02-28 | -8.63 |
